ConductScience.org, home

Gene · 4605

MYBL2: MYB proto-oncogene like 2

12 sourcesgene-search-2026-11-11-0.2.0

Download JSON
Cite this record

ConductScience Library. MYBL2: MYB proto-oncogene like 2. Genes, record 4605. Release gene-search-2026-11-11-0.2.0, 11 Nov 2026. https://conductscience.org/library/genes/4605

On this page

Gene

Symbol
MYBL2
HGNC
Name
MYB proto-oncogene like 2
HGNC
NCBI Gene ID
4605
NCBI Gene
HGNC ID
HGNC:7548
HGNC
Ensembl
ENSG00000101057
NCBI Gene
Aliases
B-MYB, BMYB
NCBI Gene
Type
protein-coding
NCBI Gene

Proteins1

Reviewed human proteins whose Swiss-Prot entry states the gene.

UniProt entryProteinLengthStructuresGene stated in
P10244Myb-related protein B7001Ensembl, GeneID, HGNC

Source UniProt

Patents61

Patents whose sequence listing contains this protein's exact sequence. A patent can list a sequence without claiming it.

PublicationPublishedSEQ ID NOProteinSource
JP 2026004568 A2026-01-1469719P10244Espacenet
EP 4641201 A22025-10-29268P10244Espacenet
EP 4641202 A22025-10-294325P10244Espacenet
JP 2025147176 A2025-10-0615323P10244Espacenet
JP 2025517969 A2025-06-12268P10244Espacenet
JP 2025028160 A2025-02-2815323P10244Espacenet
KR 1020250017231 A2025-02-044325P10244Espacenet
KR 1020250010750 A2025-01-2115323P10244Espacenet
JP 2024539140 A2024-10-285P10244Espacenet
JP 2024109657 A2024-08-1415162P10244Espacenet

1 to 10 of 61

See all 61 patents

Drugs0

Drugs a ChEMBL mechanism record says act on the gene's protein, through Open Targets.

None in this release.

Trials0

Trials of those drugs. A trial joins the gene only through a drug that acts on it.

None in this release.

NIH grants1,474

NIH grants whose papers are about the gene, through NIH's grant-paper links.

GrantTitleMYBL2 papersNewest fiscal year
P30CA016672Cancer Center Support Grant182025
P30CA008748Cancer Center Support Grant142025
P30CA016086Cancer Center Support Grant92025
P50CA058223SPORE in Breast Cancer82025
P30CA014520UW Comprehensive Cancer Center Support62025
P30CA125123Baylor College of Medicine Cancer Center - Cancer Center Support Grant62025
ZIAAG000393Influence of Post-transcriptional Gene Regulation on Cell Senescence and Aging62025
P30CA006973Regional Oncology Research Center52025
P30CA044579University of Virginia Cancer Center Support Grant52025
P01CA092584Structural Cell Biology of DNA Repair Machines42025

1 to 10 of 1,474Source NIH's project files

See all 1,474 nih grants

Papers2,561

Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.

TitleJournalYearPMIDFound bySource
An IGF2BP2-MYBL2-HMGB2 Signaling Axis Promotes Macrophage Immune Evasion in Hepatocellular Carcinoma.Cancer Commun (Lond)202642819712PubTator, text miningPubMed
Parental B-MYB/FOXM1 controls mitotic E2F to determine daughter cell fate.bioRxiv202642817988PubTator, text miningPubMed
ZFP335-MYBL2 transcriptional axis orchestrates Th17 cell differentiation and psoriatic inflammation.J Immunol202642804764PubTator, text miningPubMed
TRRAP enables MMB-dependent mitotic transcription and determines sensitivity to CHK1 inhibition.Cell Rep202642731029PubTator, text miningPubMed
MYBL2 promotes malignant phenotypes and M2-like macrophage polarization through CCL2 in non-small cell lung cancer.Mol Cell Biochem202642720907PubTator, text miningPubMed
KDM1A/HDAC2-driven epigenetic dysregulation maintains a drug-resistant, relapse-initiating glioblastoma cell niche at the peri-tumoral margin.Biochem Pharmacol202642685875PubTator, text miningPubMed
B-MYB (MYBL2): from cell cycle regulator to an oncogenic player.Biochim Biophys Acta Rev Cancer202642674117PubTator, text miningPubMed
Integrative single-nucleus transcriptomic analysis identifies UBE2C+ proliferative tumor cells and immune-stromal regulatory crosstalk in small cell lung cancer.Front Immunol202642614523PubTator, text miningPubMed
Hypoxia drives ferroptosis resistance and immunosuppression in hepatocellular carcinoma by inducing UBASH3B-mediated glutamine metabolism reprogramming and CXCL8 expression.Redox Biol202642594485PubTator, text miningPubMed
Proteome-wide Multi-omics Profiling of Osteosarcoma Transcription Factor Networks.J Mol Biol202642526587PubTator, text miningPubMed

1 to 10 of 2,561

See all 2,561 papers

Sources 12

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
  • GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
  • HGNCCC0
  • NCBI GenePublic domain (US government)
  • NIH's project files and grant-paper linksPublic domain
  • Open TargetsCC0 1.0
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
  • GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
  • HGNCCC0: https://www.genenames.org/about/license/
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this gene from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/genes/v1/4605

GET https://conductscience.org/api/genes/v1/4605/patents?page=2